Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 15, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Conformal Medical this week reported "encouraging" results for its left atrial appendage occlusion device. Fast Five hosts Danielle Kirsh and Sean Whooley discuss what the device does and what doctors think about the device.
Autonomix has completed its first procedures in its pancreatic cancer ablation trial. Learn what the trial will assess, what the technology does and how optimistic executives are.
Axonics won CE mark approval for its fourth-generation rechargeable sacral neuromodulation system. Whooley talks about what the device does and some of the other news Axonics has had recently.
SafeGuard Surgical won an FDA breakthrough nod for its biodegradable stent. Hear more about the stent, which has backing from an NFL quarterback.
Edwards reported "excellent" outcomes with its latest Sapien TAVR study. The Fast Five hosts talk about some of the data points that stuck out.
All content for Fast Five Medtech News Podcast is the property of MassDevice and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 15, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Conformal Medical this week reported "encouraging" results for its left atrial appendage occlusion device. Fast Five hosts Danielle Kirsh and Sean Whooley discuss what the device does and what doctors think about the device.
Autonomix has completed its first procedures in its pancreatic cancer ablation trial. Learn what the trial will assess, what the technology does and how optimistic executives are.
Axonics won CE mark approval for its fourth-generation rechargeable sacral neuromodulation system. Whooley talks about what the device does and some of the other news Axonics has had recently.
SafeGuard Surgical won an FDA breakthrough nod for its biodegradable stent. Hear more about the stent, which has backing from an NFL quarterback.
Edwards reported "excellent" outcomes with its latest Sapien TAVR study. The Fast Five hosts talk about some of the data points that stuck out.
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, February 9, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Baxter beat The Street in its fourth-quarter results as its kidney care spinoff progresses. Fast Five hosts Sean Whooley and Danielle Kirsh talk about the company's financial performance and how the spinoff is going.
The FDA has cleared Fresenius Medical Care's 5008X hemodialysis system. Hear more about the hemodialysis system and what makes it different.
CMR Surgical has enhanced its surgical robot with new imaging technology. Whooley explains the new imaging technology and how it helps doctors.
Biosense Webster supports a duo of new studies using Varipulse pulsed field ablation technology. Learn what the studies will evaluate in today's episode.
J&J's Cerenovus has launched a next-generation stroke revascularization catheter. The Fast Five hosts explain what the catheter is designed for, some of its features and what executives are saying.
Fast Five Medtech News Podcast
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 15, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Conformal Medical this week reported "encouraging" results for its left atrial appendage occlusion device. Fast Five hosts Danielle Kirsh and Sean Whooley discuss what the device does and what doctors think about the device.
Autonomix has completed its first procedures in its pancreatic cancer ablation trial. Learn what the trial will assess, what the technology does and how optimistic executives are.
Axonics won CE mark approval for its fourth-generation rechargeable sacral neuromodulation system. Whooley talks about what the device does and some of the other news Axonics has had recently.
SafeGuard Surgical won an FDA breakthrough nod for its biodegradable stent. Hear more about the stent, which has backing from an NFL quarterback.
Edwards reported "excellent" outcomes with its latest Sapien TAVR study. The Fast Five hosts talk about some of the data points that stuck out.
